	Assessing the concordance between ChatGPT-4 and EAU guidelines indications in bladder cancer management: a real-world study. Minerva Urol Nephrol Lo Re M, Cadenar A, Pezzoli M, Mancon S, Fuligni E, Lambertini L, Carlino A, Catanzaro R, DI Dio M, Minervini A, Cocci A. PMID: 42438987 [PubMed - indexed for MEDLINE]
	The Urological Age and Longevity Score: a step towards a targeted measure of biological aging. Minerva Urol Nephrol Akdagcik Z, Guven S, Bischof EY, Tozsin A, Caliskan M, Akgul B, Abdel-Karim A, Puliatti S, Ferretti S, Balasar M, Turkmen K, Fiori C, Tunc L, Yuan CY, Rassweiler J, Bianchi G, Herrmann T, Ahmed K. PMID: 42438985 [PubMed - indexed for MEDLINE]
	First report of safety and outcomes of radiofrequency ablation of renal tumors using a new automated energy delivery-controlled system. Minerva Urol Nephrol Ferrillo G, Baldassarre E, Sirugo T, Romano S, Lanza E, Poretti D, Saita A, Levi R, Lughezzani G, Buffi NM, Casale P, Francone M, Pedicini V. PMID: 42438982 [PubMed - indexed for MEDLINE]
	Perioperative safety and short-term survival outcomes of radical nephrectomy with thrombectomy in geriatric renal cell carcinoma patients with venous tumor thrombus. Minerva Urol Nephrol Guan Y, Hong P, Xiao R, Tang S, Liu Z, Tian X, Wang G, Ma L, Zhang H, Zhang S. PMID: 42438981 [PubMed - indexed for MEDLINE]
	How reliable are the results of clinical studies reported in urology? Minerva Urol Nephrol Bianchi G, Rodriguez Peñaranda N, Puliatti S. PMID: 42438979 [PubMed - in process]
	YAU-RCC spotlight: where evidence ends and consensus begins for renal cell carcinoma. Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025. Minerva Urol Nephrol Mollica V, Yekedüz E, Amparore D, Campi R, European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group. PMID: 42438977 [PubMed - in process]
	Clinical Efficacy of Negative Pressure Suction Combined With Digital Flexible Ureteroscopic Holmium Laser Lithotripsy in the Treatment of Infectious Renal Calculi and Its Effect of Perioperative Inflammatory Indicators. Arch Esp Urol Gao M, Chen Y, Fang W. PMID: 42438882 [PubMed - indexed for MEDLINE]
	Effects of Perioperative Continuous Nursing on Urinary Function Recovery, Lower Urinary Tract Symptom Improvement, and Postoperative Complications After Transurethral Resection of the Prostate. Arch Esp Urol Pan L, Liu J, Ru G. PMID: 42438881 [PubMed - indexed for MEDLINE]
	Navigating Accuracy and Clarity in Patient Education: The Role of AI Chatbots in Communicating Testicular Prosthesis Information. Arch Esp Urol Coser S, Aras B, Ozercan AY, Ozkaynak BN, Alkis O, Basboga S, Kartal IG, Ivelik HI. PMID: 42438879 [PubMed - indexed for MEDLINE]
	Cross-National Differences in Online Search Behavior for Urological Symptoms and Conditions: An Infodemiological Analysis. Arch Esp Urol Zengin S. PMID: 42438878 [PubMed - indexed for MEDLINE]
	The Relationship Between Diagnosis and Severity of Axial Spondyloarthritis and Overactive Bladder: A Cross-Sectional Analysis. Arch Esp Urol Cirakoglu D, Yuce A. PMID: 42438877 [PubMed - indexed for MEDLINE]
	Age as a Predictor of Prostate Cancer Risk Stratification in Systematic Prostate Biopsy. Arch Esp Urol Bostanci C, Erdem K. PMID: 42438876 [PubMed - indexed for MEDLINE]
	Survival in Synchronous Versus Metachronous Bladder and Prostate Cancer. Arch Esp Urol Yalç, Tuncay E, Arslan S, Araci HE, Köseo. PMID: 42438875 [PubMed - indexed for MEDLINE]
	Radiologic and Lipid Metabolism Imaging Features Associated with FABP2 Expression in Clear Cell Renal Cell Carcinoma: An Interpretable Supervised Machine Learning Radiogenomic Study. Arch Esp Urol Greco F, Cataldo M, Panunzio A, Tafuri A, Beomonte Zobel B, Mallio CA. PMID: 42438874 [PubMed - indexed for MEDLINE]
	Immunohistochemistry-Based Molecular Subtyping in Muscle-Invasive Bladder Cancer: Predicting Response to Neoadjuvant Chemotherapy. Arch Esp Urol Pérez-Bartivas L, Leiva-Cepas F, Ponferrada D, Flores-Paco P, Atance-Morales V, Martínez M, Armenta-Triviño A, Rodríguez-Alonso RM, De La Haba-Rodríguez J, Aranda E, Méndez-Vidal MJ. PMID: 42438872 [PubMed - indexed for MEDLINE]
	Magnetic Resonance Imaging as a Predictor of Early Discontinuation of Active Surveillance in Patients with Prostate Cancer. Arch Esp Urol Domínguez Argomedo R, de Pablos-Rodríguez P, Pelechano Gómez P, Martín García MI, Arrizabalaga Solano A, Rodríguez Part V, Beamud Cortés M, Calatrava Fons A, Gutiérrez Castañé C, Gómez-Ferrer Lozano Á, García Cortés Á, López Gonzalez JA, Domínguez Escrig JL, Romero Hinostroza C, Sánchez Aparisi E, Casanova Ramón-Borja J. PMID: 42438871 [PubMed - indexed for MEDLINE]
	Androgen Deprivation Therapy and Cardiovascular Health: Challenges and Opportunities in Prostate Cancer Care. Arch Esp Urol Fernández Alonso S, López Campos F, Büchser D, Guardado S, Andreescu J, Vásquez W, Castaño A, Gil Moradillo J, García González L, Loblaw A, Couñago F. PMID: 42438869 [PubMed - indexed for MEDLINE]
	Physical Activity During Radiotherapy in Prostate Cancer: Feasibility, Outcomes, and Clinical Integration. Arch Esp Urol Gil AMS, Tórtola-Navarro A, Blanco-Villar ML, Generoso RC, Prados AL, Mesa NAL, Galvez AS. PMID: 42438867 [PubMed - indexed for MEDLINE]
	Artificial Intelligence and Urology in Spain: From Technological Promise to Real Clinical Practice. Arch Esp Urol de la Pinta C, Medina AA. PMID: 42438866 [PubMed - indexed for MEDLINE]
	Systematic Review of Kidney Involvement in Antisynthetase Syndrome. Kidney Int Rep Wu QS, Yang L, Lin X, Wu ZL, Yu ZL, Zeng YY. PMID: 42438724 [PubMed]

Articles 1 - 20 / 476588

Page 1 of 23830



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy